David Turkaly, an analyst from JMP Securities, reiterated the Buy rating on TELA Bio (TELA – Research Report). The associated price ...

Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Tela Bio (TELA) to $5 from $8 and keeps an Overweight rating on the shares following Q3 results. The firm said gross margins were ...

Good afternoon, ladies and gentlemen and welcome to the Tela Bio third quarter, 2024. (Operators Instruction). I would now like to turn the conference over to Louisa Smith from the Gilmartin Group.

The Texas Department of Licensing and Regulation states that "contestants who are age 36 or older, must submit a report of ...

Jake Paul proposed a different rule to the Texas Department of Licensing and Regulations for the Mike Tyson fight before a ...

Full Year Revenue Guidance: $74.5 million to $76.5 million for 2024, reflecting growth of 28% to 31% over 2023. TELA Bio Inc ...

In 1976, Muhammad Ali fought Japanese wrestler Antonio Inoki in Japan. In 2017, Floyd Mayweather, at 40 years old, came out ...

Gross profit was $12.9 million in the third quarter of 2024, or 68% of revenue, compared to $10.4 million, or 69% of revenue, in the same period in 2023. The decrease in gross margin was primarily due ...

Boxing icon Mike Tyson is set to undergo last-ditch medical tests before his highly anticipated fight against internet ...

A menacing, 58-year-old Tyson looked ready to knock someone out in the final news brief before the big event, promising: ‘I’m ...

On Friday, Piper Sandler adjusted its outlook on TELA Bio, Inc. (NASDAQ: NASDAQ:TELA) shares, a medical technology company, reducing the price target to $5 from the prior $8. Despite this change ...